Electroacupuncture  	Electroacupuncture  	 JJ	B-NP
inhibits  	inhibits  	 JJ	O
inflammatory  	inflammatory  	 JJ	B-NP
injury  	injury  	 NN	I-NP
by  	by  	 IN	O
targeting  	targeting  	 VBG	O
the  	the  	 DT	O
miR‑9‑mediated  	miR‑9‑mediated  	 FW	B-NP
NF‑κB  	NF‑κB  	 FW	O
signaling  	signaling  	 FW	B-NP
pathway  	pathway  	 FW	I-NP
following  	following  	 FW	O
ischemic  	ischemic  	 FW	B-NP
stroke  	stroke  	 FW	I-NP
The  	The  	 DT	O
aim  	aim  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
neuroprotective  	neuroprotective  	 JJ	B-NP
mechanism  	mechanism  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
miR‑9‑mediated  	miR‑9‑mediated  	 JJ	I-NP
activation  	activation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
nuclear  	nuclear  	 JJ	B-NP
factor  	factor  	 NN	I-NP
( 	( 	 -LRB-	O
NF 	NF 	 NNP	B-NP
) 	) 	 -RRB-	O
‑κB  	‑κB  	 VBP	O
signaling  	signaling  	 VBG	B-NP
pathway  	pathway  	 NN	I-NP
by  	by  	 IN	O
electroacupuncture  	electroacupuncture  	 NNS	B-NP
( 	( 	 -LRB-	O
EA 	EA 	 NNP	B-NP
)  	)  	 -RRB-	O
stimulation  	stimulation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Quchi  	Quchi  	 NNP	B-NP
( 	( 	 -LRB-	O
LI11 	LI11 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
Zusanli  	Zusanli  	 NNP	B-NP
( 	( 	 -LRB-	O
ST36 	ST36 	 NNP	B-NP
)  	)  	 -RRB-	O
acupoints  	acupoints  	 NN	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
rat  	rat  	 JJ	O
model  	model  	 NN	O
of  	of  	 IN	O
middle  	middle  	 JJ	B-NP
cerebral  	cerebral  	 JJ	I-NP
artery  	artery  	 NN	I-NP
occlusion  	occlusion  	 NNS	I-NP
( 	( 	 -LRB-	O
MCAO 	MCAO 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
demonstrated  	demonstrated  	 VBN	O
that  	that  	 IN	O
EA  	EA  	 NNP	B-NP
alleviated  	alleviated  	 VBD	O
the  	the  	 DT	O
symptoms  	symptoms  	 NNS	B-NP
of  	of  	 IN	I-NP
neurological  	neurological  	 JJ	I-NP
deficits  	deficits  	 NNS	I-NP
and  	and  	 CC	O
reduced  	reduced  	 VBD	O
the  	the  	 DT	O
infarct  	infarct  	 JJ	B-NP
volume  	volume  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
rat  	rat  	 JJ	O
brains 	brains 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
miR‑9 in  	miR‑9 in  	 CD	B-NP
the  	the  	 DT	O
peri‑infarct  	peri‑infarct  	 CD	O
cortex  	cortex  	 NNS	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
EA  	EA  	 NNP	B-NP
group  	group  	 NN	I-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
MCAO  	MCAO  	 NNP	B-NP
group 	group 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
NF‑κB  	NF‑κB  	 CD	B-NP
signaling  	signaling  	 CD	O
pathway‑associated  	pathway‑associated  	 CD	O
factors 	factors 	 NNS	O
,  	,  	 ,	O
NF‑κB  	NF‑κB  	 NNP	B-NP
p65 	p65 	 NNP	O
,  	,  	 ,	O
tumor  	tumor  	 NN	B-NP
necrosis  	necrosis  	 NN	I-NP
factor  	factor  	 NN	I-NP
( 	( 	 -LRB-	O
TNF 	TNF 	 NNP	B-NP
) 	) 	 -RRB-	O
‑α  	‑α  	 NNP	O
and  	and  	 CC	O
interleukin  	interleukin  	 NNS	B-NP
( 	( 	 -LRB-	O
IL 	IL 	 NNP	B-NP
) 	) 	 -RRB-	O
‑1β  	‑1β  	 NNP	O
were  	were  	 VBD	O
reduced 	reduced 	 VBN	O
.  	.  	 .	O
Notably 	Notably 	 RB	O
,  	,  	 ,	O
miR‑9 inhibitors  	miR‑9 inhibitors  	 NNP	B-NP
were  	were  	 VBD	O
revealed  	revealed  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
suppress  	suppress  	 VB	O
EA‑alleviated  	EA‑alleviated  	 CD	B-NP
cerebral  	cerebral  	 CD	O
inflammation  	inflammation  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
NF‑κB  	NF‑κB  	 CD	B-NP
downstream‑related  	downstream‑related  	 CD	O
factors 	factors 	 NNS	O
,  	,  	 ,	O
NF‑κB  	NF‑κB  	 NNP	B-NP
p65 	p65 	 NNP	O
,  	,  	 ,	O
TNF‑α  	TNF‑α  	 NNP	B-NP
and  	and  	 CC	O
IL‑1β 	IL‑1β 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
caused  	caused  	 VBD	O
no  	no  	 DT	O
alteration  	alteration  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
NF‑κB  	NF‑κB  	 CD	B-NP
upstream‑related  	upstream‑related  	 CD	O
protein  	protein  	 NN	B-NP
inhibitor  	inhibitor  	 NN	I-NP
of  	of  	 IN	I-NP
κBα 	κBα 	 NNP	I-NP
,  	,  	 ,	O
suggesting  	suggesting  	 VBG	O
that  	that  	 IN	O
the  	the  	 DT	O
cerebral  	cerebral  	 JJ	B-NP
protective  	protective  	 JJ	I-NP
efficacy  	efficacy  	 NN	I-NP
of  	of  	 IN	I-NP
EA  	EA  	 NNP	I-NP
targets  	targets  	 FW	I-NP
miR‑9‑mediated  	miR‑9‑mediated  	 FW	I-NP
NF‑κB  	NF‑κB  	 FW	O
downstream  	downstream  	 FW	O
pathway  	pathway  	 FW	O
following  	following  	 FW	O
ischemic  	ischemic  	 FW	B-NP
stroke 	stroke 	 FW	I-NP
.  	.  	 .	O
